Meritage Homes Corporation (NYSE: MTH) is a US homebuilder focused on entry-level and first move-up homes in Sun Belt markets such as Texas, Florida, and Arizona. Its analyst coverage has turned decisively more cautious after the company's latest quarterly report.
The full set of current targets spans roughly $59 to $85. S&P Global's aggregate, which polls nine analysts, puts the average around $71 — only slightly above the current price and well short of the 10% premium needed for a meaningful objective. Because that consensus sits essentially at the market, the $84 target used here is the arithmetic mean of only the targets above the current price: UBS at $85 and Goldman Sachs at $82. This is not an official published consensus; it is a calculated figure for discussion.
The dispersion is unusually wide. UBS (John Lovallo) and Goldman Sachs retain Buy ratings, arguing the shares trade at a discount to intrinsic value. In contrast, Melius Research initiated coverage with a Sell and a $59 target in early October, while Truist, Evercore ISI, and KBW all cut targets to the low-to-mid $60s with Hold ratings after the company withdrew guidance. The gap between $59 and $85 reflects genuine disagreement over whether affordability pressures are temporary or structural.
With the stock near $68.70, reaching $84 implies upside of about 22%, a substantial move by any standard. The path is not straightforward. Third-quarter 2026 revenue fell 17.9% year over year to $1.17 billion, missing consensus, while adjusted EPS (earnings per share) of $1.11 came in slightly below expectations. Management withdrew guidance across all metrics, citing weak visibility, and Truist noted that incentives are likely to remain elevated into 2027 unless the spring selling season surprises to the upside.
Still, the shares have rebounded from the roughly $58 level hit immediately after the earnings release, suggesting investors are weighing depressed expectations against a historically cheap valuation and a resilient balance sheet. A move toward $84 would require not just stabilization in orders and margins but a re-rating of the multiple as mortgage rates ease and confidence recovers.
The post-earnings drop to roughly $58 established a near-term support zone, and the subsequent recovery toward the high $60s shows buyers defending that area. The mid-$60s, where several analyst targets cluster, has acted as a battleground. A sustained move above that range would be a necessary first step before the $84 target becomes relevant, though the stock would need to overcome the psychological $70 level and the broader downward trend in orders and margins that has defined the past year.
Analyst price targets typically reflect a research horizon of around 12 months, though individual firms do not always state this explicitly. Key items to watch include the next quarterly earnings release and any resumption of guidance, mortgage-rate movements and Federal Reserve policy, order and absorption trends, gross-margin performance, incentive levels, and the pace of share buybacks. Revisions to the low-$60s targets — or renewed bullish commentary from the Buy-rated firms — would be important signals on whether the $84 level remains realistic.
Tickeron's AI Daily Buy/Sell Signals use artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on changing market conditions, technical behavior, and AI-driven analysis. For a volatile name like Meritage Homes, such tools can help traders spot shifting trends, monitor positions, and discover opportunities more efficiently than manual scanning. Explore the signals to see how the platform's models are currently reading MTH's momentum and risk profile.
The $84 target is best understood as the average of the two current analyst targets above the market — UBS at $85 and Goldman Sachs at $82 — rather than a broad consensus. It requires a substantial gain of about 22% from a price near $68.70. The bull case rests on a fortress balance sheet, ongoing buybacks, and a long-term housing shortage, while the bear case centers on 7%-plus mortgage rates, shrinking orders, and a withdrawn outlook that has left analysts split between a $59 Sell and an $85 Buy. Whether the shares can reach $84 hinges on mortgage-rate relief, a stabilization in orders and margins, and a restoration of investor confidence in guidance. That outcome is possible but far from assured.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
A.I.dvisor indicates that over the last year, MTH has been closely correlated with PHM. These tickers have moved in lockstep 89% of the time. This A.I.-generated data suggests there is a high statistical probability that if MTH jumps, then PHM could also see price increases.